مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

413
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

196
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

DECREASED URINARY LEVEL OF MELATONIN AS A MARKER OF DISEASE SEVERITY IN PATIENTS WITH MULTIPLE SCLEROSIS

Pages

  91-97

Abstract

 Melatonin has both pro-inflammatory and anti-inflammatory properties depending on the stage of inflammation. Despite its therapeutic effect in alleviation of some symptoms of MULTIPLE SCLEROSIS; the precise role of MELATONIN in MS pathogenesis remains a topic of debate. The aim of this study was to measure the urine level of one of MELATONIN products which is an index of serum MELATONIN level, in MS patients in the acute phase of relapse and control patients. We also analyzed different clinical and cognitive indices in order to find any correlation with MELATONIN level.Twenty eight patients who were diagnosed as relapsing-remitting MS, according to the revised McDonald criteria, along with 10 age- and sex-matched control subjects were recruited in our study.Here we showed that urine 6-sulphatoxymelatonin levels (aMT6s; the major metabolite of MELATONIN) were significantly lower in MS patients compared to control group. Interestingly, urine aMT6s levels significantly correlated with MS Functional Composite score, but not Expanded Disability Severity Score.Based on above findings, there might be new hope in developing a quantitative and objective measure to assess the MS severity especially in neurodegenerative diseases. However, our results should be analyzed cautiously. We didn’t evaluate simultaneous level of 25-OH Vitamin D. It has been recently reported that there is a negative correlation between MELATONIN and vitamin D levels. Further studies are needed to confirm this hypothesis.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    GHOLIPOUR, TAHA, GHAZIZADEH, TAHER, BABAPOUR, SAHAND, MANSOURI, BEHZAD, GHAFFARPOUR, MAJID, SIROOS, BAHAADIN, & HARIRCHIAN, MOHAMMAD HOSSEIN. (2015). DECREASED URINARY LEVEL OF MELATONIN AS A MARKER OF DISEASE SEVERITY IN PATIENTS WITH MULTIPLE SCLEROSIS. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), 14(1), 91-97. SID. https://sid.ir/paper/291409/en

    Vancouver: Copy

    GHOLIPOUR TAHA, GHAZIZADEH TAHER, BABAPOUR SAHAND, MANSOURI BEHZAD, GHAFFARPOUR MAJID, SIROOS BAHAADIN, HARIRCHIAN MOHAMMAD HOSSEIN. DECREASED URINARY LEVEL OF MELATONIN AS A MARKER OF DISEASE SEVERITY IN PATIENTS WITH MULTIPLE SCLEROSIS. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI)[Internet]. 2015;14(1):91-97. Available from: https://sid.ir/paper/291409/en

    IEEE: Copy

    TAHA GHOLIPOUR, TAHER GHAZIZADEH, SAHAND BABAPOUR, BEHZAD MANSOURI, MAJID GHAFFARPOUR, BAHAADIN SIROOS, and MOHAMMAD HOSSEIN HARIRCHIAN, “DECREASED URINARY LEVEL OF MELATONIN AS A MARKER OF DISEASE SEVERITY IN PATIENTS WITH MULTIPLE SCLEROSIS,” IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), vol. 14, no. 1, pp. 91–97, 2015, [Online]. Available: https://sid.ir/paper/291409/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button